DALLAS--(BUSINESS WIRE)--Recuro Health (Recuro), an integrated digital health solutions company that transitions the U.S. healthcare system from a reactive, disease-focused model to a population health, outcomes approach, today announces investments by DeepWork Capital and GPG Ventures, bringing the total current investment in Recuro to $22 million. These financial sponsors join existing investors in the over-subscribed A-Round, including ARCH Venture Partners, OLSF Ventures, Cortado Ventures, 1843 Capital and Sage Venture Partners.
Michael Gorton, CEO and founder of Recuro Health, says, “The overwhelming response to Recuro in the financial community demonstrates market confidence in our leadership team, the growing range of innovative digital health solutions and the strides we are already making to bring more affordable, accessible healthcare to individuals nationwide. The relationships with DeepWork Capital and GPG further accelerate our growth and enable Recuro to better serve the needs of providers, payers and patients.”
Recuro’s curated and integrated suite of digital solutions address real market challenges and impact care delivery at the intersection of quality, access and cost. From virtual primary care and behavioral telehealth to at-home testing and genetic screening, its fully customizable portfolio of solutions can be tailored to meet the needs of any population.
According to Benjamin Patz, managing partner of DeepWork Capital, “Recuro exemplifies this spirit of innovation by advancing integrated care, risk stratification and diagnostics. Recuro is truly an innovative healthcare solution provider, with a robust business model that results in improved outcomes and more efficient care.”
Recuro has had early success and market recognition with its COVID-19 testing solution which is one of a dozen chosen from a field of hundreds of companies to collaborate directly with the US Department of Health and Human Services, the National Institute of Health and the FDA during the pandemic.
Dr. Clay Heighten, GPG Ventures, says, “Recuro is aligned with our goal to bring compelling investment opportunities to our limited partners. The exceptional executive leadership team is demonstrating the value of recognizing market opportunities and creating programs and services that answer pressing healthcare needs. Recuro is addressing many of the new, post-COVID patient preferences for delivery of healthcare.”
Gorton says, “Recuro’s success is built on strong partnerships, technical expertise and a proven ability to deliver superior results. Our overall strategy is to invest in projects that generate long-term value with an integrated business model that combines world-class assets and leadership in advancing healthcare access and outcomes.”
About Recuro Health
Serving payers, employers and providers, Recuro Health is an integrated digital health solution that delivers value throughout the healthcare ecosystem as care moves from traditional office in-person settings to wherever the patient and data are located. Recuro solutions support the migration from convenient care to meaningful patient engagement across broader care pathways, creating a personalized, holistic digital medical home that results in better outcomes and lower costs. www.recurohealth.com.
About DeepWork Capital
DeepWork Capital invests professionally managed committed venture capital in growth-oriented, early-stage companies in the technology and life science sectors. We partner with visionary entrepreneurs building disruptive companies. DeepWork works closely with other investment groups and takes a hands-on approach with its portfolio companies. For additional information, please see https://www.deepworkcapital.com.
About GPG Ventures
GPG Ventures is an early-stage investment firm focused primarily in healthcare with ability to invest in other industries and across stages. We are headquartered in Texas, with offices in Dallas and Houston and portfolio companies across the US. GPG Ventures.
